Stover E P, Loose D S, Stevens D A, Feldman D
Biochem Biophys Res Commun. 1983 Nov 30;117(1):43-50. doi: 10.1016/0006-291x(83)91538-3.
Ketoconazole is a broad-spectrum, orally-active antifungal agent that has been shown to inhibit sterol synthesis in susceptible fungi. We have previously demonstrated the presence of an intracellular protein in several Candida species that binds mammalian corticosteroids with high affinity. In this paper we report that ketoconazole competitively displaces [3H]corticosterone from the Candida corticosteroid-binding protein at concentrations readily achieved in therapeutic settings. Ketoconazole was at least 50-100 times more potent than structurally related imidazole compounds. Additional data suggest, however, that the binding of ketoconazole and related drugs to this Candida protein is not critical for the in vitro antifungal activity of these drugs.
酮康唑是一种广谱口服活性抗真菌剂,已被证明可抑制敏感真菌中的甾醇合成。我们之前已经证明,几种念珠菌属中存在一种细胞内蛋白,该蛋白能与哺乳动物皮质类固醇高亲和力结合。在本文中我们报告,酮康唑在治疗环境中容易达到的浓度下,能竞争性地从念珠菌皮质类固醇结合蛋白上取代[3H]皮质酮。酮康唑的效力比结构相关的咪唑化合物至少强50至100倍。然而,其他数据表明,酮康唑及相关药物与这种念珠菌蛋白的结合对于这些药物的体外抗真菌活性并不关键。